Global Vascular Access Device Market
Vascular Access Device Market

Report ID: SQMIG35A3156

sales@skyquestt.com
USA +1 351-333-4748

Vascular Access Device Market Size, Share, and Growth Analysis

Global Vascular Access Device Market

Vascular Access Device Market By Product (Short Peripheral Intravenous Catheter, Huber Needles), By End Use (Hospitals, Ambulatory care centers), By Region - Industry Forecast 2026-2033


Report ID: SQMIG35A3156 | Region: Global | Published Date: January, 2026
Pages: 195 |Tables: 91 |Figures: 71

Format - word format excel data power point presentation

Vascular Access Device Market Insights

Global Vascular Access Device Market size was valued at USD 9.28 Billion in 2024 and is poised to grow from USD 9.78 Billion in 2025 to USD 14.89 Billion by 2033, growing at a CAGR of 5.4% during the forecast period (2026–2033). 

One of the strongest primary drivers of the Global Vascular Access Device Market is the growing burden of chronic diseases such as cancer, diabetes, kidney disorders, and cardiovascular conditions. These diseases frequently require prolonged treatments like chemotherapy, dialysis, parenteral nutrition, or long-term medication delivery, all of which depend on safe and efficient vascular access. As global populations age and lifestyles contribute to higher rates of chronic illnesses, the need for durable and reliable vascular access devices rises. This growing patient pool directly fuels market expansion, as healthcare providers increasingly adopt advanced devices to ensure effective and continuous treatment.

A key trend driving the global vascular access device market is ongoing technological innovation. Manufacturers are focusing on developing next-generation devices such as antimicrobial-coated catheters, safety-engineered needles, and minimally invasive insertion systems that reduce infection rates, thrombosis, and other complications. These advancements improve patient comfort, extend device longevity, and minimize hospital readmissions due to device-related issues. Healthcare providers are increasingly prioritizing devices that enhance safety and treatment efficiency, aligning with global emphasis on quality care. As a result, technological improvements not only strengthen clinical outcomes but also encourage wider adoption of advanced vascular access devices worldwide.

How does AI Advancement Reduce Procedural Errors in Vascular Access?

Artificial intelligence is significantly influencing the Global Vascular Access Device Market by improving device efficiency, safety, and clinical decision-making. AI-powered predictive analytics enable early detection of complications like thrombosis or infections, allowing timely intervention and reducing device failure rates. For instance, Diaverum developed an AI model that predicts vascular access to thrombosis in dialysis patients up to a week in advance, enhancing preventive care. Similarly, AI-guided ultrasound systems assist healthcare providers in precise catheter placement, even with limited training. These advancements reduce procedural errors, enhance patient outcomes, and push manufacturers to integrate AI-driven features, accelerating market innovation and adoption.

Philips introduced LumiGuide in February 2024, using its Fiber Optic RealShape (FORS) technology to enable light-based navigation of guidewires and catheters. The system includes an AI-based recognition feature that automatically registers the guidewire inside the body, improving precision and reducing reliance on X-ray imaging.

Market snapshot - 2026-2033

Global Market Size

USD 5.60 Billion

Largest Segment

Central Venous Access Devices

Fastest Growth

Peripheral Vascular Access Devices

Growth Rate

7.1% CAGR

Global Vascular Access Device Market 2026-2033 ($ Bn)
Country Share by North America 2025 (%)

To get more insights on this market click here to Request a Free Sample Report

Vascular Access Device Market Segments Analysis

Global Vascular Access Device Market is segmented by Product, End Use and region. Based on Product, the market is segmented into Short Peripheral Intravenous Catheter, Huber Needles, Midline Catheters, Peripherally Inserted Central Catheter (PICCs), Central Venous Catheter (CVCs), Dialysis Catheters and Implantable Ports. Based on End Use, the market is segmented into Hospitals, Ambulatory care centers and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.  

How do CVADs Support Long-Term Medication and Therapy?

Based on the global vascular access device market forecast, central venous access devices (CVADs) are dominating the industry, with advancements such as antimicrobial coatings, AI-assisted insertion, and ultrasound-guided placement enhancing safety and precision. Their widespread use in chemotherapy, long-term medication, and parenteral nutrition drives consistent demand. CVADs dominate the market due to their ability to support prolonged therapy, reduce infection risks, and provide reliable access for complex treatments, making them indispensable in modern healthcare.

Peripheral Vascular Access Devices (PVADs) are projected to be the fastest-growing segment in the global vascular access device market due to their ease of use, minimal invasiveness, and suitability for short-term therapies. Rising outpatient treatments, increasing home healthcare services, and technological improvements like safety-engineered catheters are driving rapid adoption worldwide.

How does the IV Route Support Both Short- and Long-Term Treatments?

The intravenous (IV) route of insertion remains the most widely used in the global vascular access device market due to its versatility and efficiency in delivering fluids, medications, and nutrition. Innovations such as AI-assisted catheter placement, ultrasound guidance, and antimicrobial coatings enhance accuracy, safety, and patient comfort. Its dominance stems from broad clinical applicability, suitability for both short- and long-term therapies, and reduced procedural complications, making it the preferred choice for healthcare providers globally.

The intraosseous (IO) route of insertion is expected to be the fastest-growing segment in the global vascular access device market due to its rapid, reliable access during emergencies when intravenous insertion is difficult. Increasing adoption in critical care, trauma, and pediatric applications, along with improved IO device designs, is driving its growth globally.

Global Vascular Access Device Market By Type 2026-2033 (%)

To get detailed segments analysis, Request a Free Sample Report

Vascular Access Device Market Regional Insights

What makes North America a Key Hub for Vascular Device Development and Commercialization?

As per the global vascular access device market analysis, North America dominates the industry, driven by advanced healthcare infrastructure, high prevalence of chronic diseases, and widespread adoption of technologically advanced devices. Continuous R&D, strong presence of leading manufacturers, and favorable reimbursement policies support market growth. Additionally, increasing demand for minimally invasive procedures, AI-assisted insertion systems, and safety-engineered devices further reinforce North America’s position as a key regional leader in vascular access solutions.

US Vascular Access Device Market

The United States is the largest contributor to North America’s vascular access device market, driven by advanced healthcare infrastructure, high patient volumes, and early adoption of innovative technologies such as AI-assisted and ultrasound-guided vascular access devices. Rising prevalence of chronic diseases, increasing outpatient procedures, and supportive reimbursement policies encourage widespread use. Strong R&D initiatives by key domestic and multinational manufacturers further reinforce the U.S. market’s leadership and influence in the regional vascular access segment.

Canada Vascular Access Device Market

Canada contributes significantly to North America’s vascular access device market due to growing demand for safe, minimally invasive vascular access solutions across hospitals and home healthcare settings. Government-supported healthcare policies, increasing chronic disease prevalence, and adoption of advanced devices like antimicrobial-coated catheters and ultrasound-guided systems drive market growth. Investments in clinician training, innovation in device design, and focus on patient safety further strengthen Canada’s role in expanding vascular access device utilization regionally.

Why are Minimally Invasive Procedures Becoming more Popular in Asia Pacific?

The Asia Pacific vascular access device market is witnessing rapid growth, fueled by rising chronic disease prevalence, expanding healthcare infrastructure, and increasing adoption of advanced medical technologies. Countries like China, Japan, and India lead in device utilization, supported by growing awareness of patient safety and minimally invasive procedures. Investments in AI-assisted and ultrasound-guided devices, coupled with favorable government initiatives and rising healthcare expenditure, are driving market expansion across the region.

Japan Vascular Access Device Market

Japan is a key contributor to the Asia Pacific vascular access device market, driven by an aging population, high prevalence of chronic diseases, and advanced healthcare infrastructure. The country emphasizes minimally invasive procedures, safety-engineered devices, and AI-assisted vascular access technologies. Strong government support, robust R&D investment, and high adoption of innovative catheters and insertion systems position Japan as a leading market, significantly influencing regional growth and technological advancement in vascular access solutions.

South Korea Vascular Access Device Oil Market

South Korea contributes significantly to the Asia Pacific vascular access device market through its technologically advanced healthcare system and growing demand for safe, efficient vascular access. Adoption of ultrasound-guided and AI-enabled insertion devices, antimicrobial-coated catheters, and minimally invasive solutions is increasing rapidly. Rising chronic disease prevalence, government initiatives promoting healthcare innovation, and investments in clinical training and research strengthen South Korea’s role, making it a key driver of regional vascular access device growth.

What Role do Safety-Engineered Devices Play in Enhancing Patient Care Across Europe?

Europe’s vascular access device market is expanding steadily, driven by increasing chronic disease prevalence, an aging population, and rising demand for minimally invasive treatments. Strong healthcare infrastructure, advanced medical technologies, and growing adoption of AI-assisted and safety-engineered devices support growth. Key markets such as Germany, France, and the UK lead in innovation and usage, while favorable regulatory frameworks, reimbursement policies, and continuous R&D investments reinforce Europe’s position as a major regional player.

Germany Vascular Access Device Oil Market

Germany is a leading contributor to Europe’s vascular access device market, driven by advanced healthcare infrastructure, high chronic disease prevalence, and early adoption of innovative devices. The country emphasizes minimally invasive procedures, AI-assisted catheter placement, and safety-engineered systems. Strong R&D initiatives by domestic and multinational manufacturers, along with supportive reimbursement policies and clinical guidelines, enhance device utilization, making Germany a key driver of Europe’s growth in vascular access solutions.

France Vascular Access Device Oil Market

France plays a significant role in Europe’s vascular access device market due to its robust healthcare system and focus on patient safety. Widespread adoption of antimicrobial-coated catheters, ultrasound-guided insertions, and AI-enabled vascular access devices supports market expansion. High incidence of chronic diseases, increasing outpatient treatments, and government-backed reimbursement frameworks further drive demand. France’s emphasis on innovation and clinical training strengthens its position as a major contributor in the regional vascular access segment.

UK Vascular Access Device Oil Market

The UK plays a significant role in Europe’s vascular access device market due to its robust healthcare system and focus on patient safety. Widespread adoption of antimicrobial-coated catheters, ultrasound-guided insertions, and AI-enabled vascular access devices supports market expansion. High incidence of chronic diseases, increasing outpatient treatments, and government-backed reimbursement frameworks further drive demand. France’s emphasis on innovation and clinical training strengthens its position as a major contributor in the regional vascular access segment.

Global Vascular Access Device Market By Geography, 2026-2033
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Vascular Access Device Market Dynamics

Vascular Access Device Market Drivers

Rising Prevalence of Chronic Diseases

  • The increasing incidence of chronic diseases such as cancer, kidney disorders, and cardiovascular conditions drives the global vascular access device market growth. These conditions require long-term therapies, including chemotherapy, dialysis, and intravenous medication. As patient numbers grow, healthcare providers adopt advanced devices to ensure efficient treatment delivery, patient safety, and reduced procedural complications.

Technological Advancements in Device Design

  • Continuous innovations in vascular access devices, including antimicrobial coatings, AI-assisted insertion systems, and ultrasound-guided catheters, enhance safety, accuracy, and patient comfort. These improvements reduce complications, procedural time, and hospital readmissions. Growing clinician preference for advanced devices accelerates market adoption, encouraging manufacturers to invest in R&D and develop next-generation vascular access solutions globally.

Vascular Access Device Market Restraints

Risk of Device-Related Complications

  • Complications such as infections, thrombosis, and catheter malfunctions can occur despite advanced designs, discouraging some healthcare providers from adopting vascular access devices. Concerns over patient safety, need for skilled insertion, and potential legal liabilities create hesitation, thereby restraining market growth and emphasizing the need for continuous training and improved device safety measures.

Limited Awareness in Emerging Markets

  • In many emerging markets, lack of awareness about the benefits of advanced vascular access devices among healthcare providers and patients restricts adoption. Limited training, insufficient infrastructure, and low healthcare budgets reduce demand, slowing market growth in these regions despite rising chronic disease prevalence and increasing need for minimally invasive therapies.

Request Free Customization of this report to help us to meet your business objectives.

Vascular Access Device Market Competitive Landscape

The global vascular access device market outlook is highly competitive, dominated by international players such as Becton Dickinson, Teleflex, Medtronic, Smiths Medical, and Terumo Corporation. Companies focus on innovation, mergers, acquisitions, and strategic partnerships to expand their market presence. For instance, Becton Dickinson emphasizes AI-assisted and safety-engineered devices, while Teleflex invests in minimally invasive solutions. Medtronic leverages R&D to enhance catheter technology, and Terumo targets emerging markets through localized production and distribution strategies.

As per the global vascular access device industry analysis, the market is witnessing growth fuelled by innovative startups addressing unmet clinical needs. These emerging companies focus on enhancing patient safety, reducing complications, and improving procedural efficiency. By introducing advanced devices, AI-assisted technologies, and monitoring solutions, startups are challenging traditional approaches and driving technological evolution. Their agile R&D strategies and targeted solutions are accelerating adoption of safer, minimally invasive vascular access devices, shaping the future of the market globally.

  • Founded in 2015, Access Vascular, Inc. focuses on improving vascular access safety and efficacy. Its key product, BioFlo® catheter, incorporates a proprietary biomaterial that reduces thrombosis and infection risks. This innovation enhances patient outcomes, minimizes healthcare costs, and decreases the need for catheter replacements. By integrating advanced materials and design improvements, Access Vascular provides a safer, more efficient solution for vascular access procedures, establishing itself as a prominent startup in the global vascular access device market.
  • Established in 2023, HemaSense focuses on improving vascular access site safety and monitoring. Its flagship monitoring device detects subcutaneous blood accumulation at catheter sites, providing real-time alerts for early intervention. The breakthrough innovation lies in its non-invasive early detection technology, which minimizes hematomas and other complications. By enabling timely interventions, the device enhances patient safety, reduces hospital stays, and improves recovery outcomes, establishing HemaSense as a key innovator in vascular access management.

Top Player’s Company Profiles

  • Becton, Dickinson and Company (BD) (U.S.) 
  • Teleflex Incorporated (U.S.) 
  • B. Braun SE (Germany) 
  • ICU Medical, Inc. (U.S.) 
  • Medtronic plc (Ireland) 
  • AngioDynamics, Inc. (U.S.) 
  • Terumo Corporation (Japan) 
  • Cook Medical (U.S.) 
  • Baxter International Inc. (U.S.) 
  • Fresenius Medical Care (Germany) 
  • NIPRO Medical Corporation (Japan) 
  • Vygon SA (France) 
  • Merit Medical Systems, Inc. (U.S.) 
  • Siemens Healthineers (Germany) 
  • Edwards Lifesciences Corporation (U.S.) 
  • PRODIMED (France) 
  • 3M Company (U.S.) 
  • Access Vascular, Inc. (U.S.) 
  • Medical Components, Inc. (U.S.) 
  • AMECATH (Egypt) 

Recent Developments in Vascular Access Device Market

  • In March 2024, Medtronic received FDA approval for its newest-generation Evolut FX+ TAVR system for treating symptomatic severe aortic stenosis. The device offers improved catheter maneuverability and access to varying coronary anatomies, enhancing procedural precision and outcomes. This advancement allows safer, minimally invasive treatment for high-risk patients, supporting broader adoption of advanced vascular access procedures globally.
  • In May 2024, Teleflex expanded its intraosseous vascular access portfolio with the Arrow™ EZ-IO™ Procedure Tray. This single-use, sterile tray contains all components for IO access, streamlining the procedure and reducing preparation time. Designed for emergency and critical care settings, it enhances clinician workflow efficiency and ensures rapid, safe vascular access during time-sensitive patient interventions.
  • In October 2024, BD launched its enhanced intraosseous (IO) system, enabling rapid vascular access in critical care scenarios. The device allows swift insertion into the bone marrow for immediate fluid and medication delivery when intravenous access is difficult. Its integrated passive needle tip safety protects patients and healthcare providers from needlestick injuries, improving clinical efficiency and safety.

Vascular Access Device Key Market Trends

Vascular Access Device Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, the global vascular access device industry is experiencing robust growth, driven by the rising prevalence of chronic diseases, technological advancements, and AI integration. Increasing patient populations requires safe, efficient, and durable vascular access solutions, while innovations such as antimicrobial coatings, safety-engineered needles, and AI-guided insertion enhance clinical outcomes.

Central Venous Access Devices dominate due to prolonged therapy support, while Peripheral and Intraosseous devices grow rapidly through minimally invasive and emergency applications. Regional leaders, including North America, Europe, and Asia-Pacific, leverage advanced healthcare infrastructure, R&D, and supportive policies to expand adoption. Startups and established players continue to innovate, focusing on patient safety, efficiency, and predictive analytics, ensuring sustained global vascular access device market revenue expansion and improved global healthcare delivery.

Report Metric Details
Market size value in 2024 USD 9.28 Billion
Market size value in 2033 USD 14.89 Billion
Growth Rate 5.4%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Short Peripheral Intravenous Catheter ,Huber Needles ,Midline Catheters ,Peripherally Inserted Central Catheter (PICCs) ,Dialysis Catheters ,Implantable Ports
  • End Use
    • Hospitals ,Ambulatory care centers ,Other end use
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Becton, Dickinson and Company (BD) (U.S.) 
  • Teleflex Incorporated (U.S.) 
  • B. Braun SE (Germany) 
  • ICU Medical, Inc. (U.S.) 
  • Medtronic plc (Ireland) 
  • AngioDynamics, Inc. (U.S.) 
  • Terumo Corporation (Japan) 
  • Cook Medical (U.S.) 
  • Baxter International Inc. (U.S.) 
  • Fresenius Medical Care (Germany) 
  • NIPRO Medical Corporation (Japan) 
  • Vygon SA (France) 
  • Merit Medical Systems, Inc. (U.S.) 
  • Siemens Healthineers (Germany) 
  • Edwards Lifesciences Corporation (U.S.) 
  • PRODIMED (France) 
  • 3M Company (U.S.) 
  • Access Vascular, Inc. (U.S.) 
  • Medical Components, Inc. (U.S.) 
  • AMECATH (Egypt) 
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Vascular Access Device Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Vascular Access Device Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Vascular Access Device Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Vascular Access Device Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Vascular Access Device Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Vascular Access Device Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Vascular Access Device Market size was valued at USD 9.28 Billion in 2024 and is poised to grow from USD 9.78 Billion in 2025 to USD 14.89 Billion by 2033, growing at a CAGR of 5.4% during the forecast period (2026–2033). 

The global vascular access device market outlook is highly competitive, dominated by international players such as Becton Dickinson, Teleflex, Medtronic, Smiths Medical, and Terumo Corporation. Companies focus on innovation, mergers, acquisitions, and strategic partnerships to expand their market presence. For instance, Becton Dickinson emphasizes AI-assisted and safety-engineered devices, while Teleflex invests in minimally invasive solutions. Medtronic leverages R&D to enhance catheter technology, and Terumo targets emerging markets through localized production and distribution strategies. 'Becton, Dickinson and Company (BD) (U.S.) ', 'Teleflex Incorporated (U.S.) ', 'B. Braun SE (Germany) ', 'ICU Medical, Inc. (U.S.) ', 'Medtronic plc (Ireland) ', 'AngioDynamics, Inc. (U.S.) ', 'Terumo Corporation (Japan) ', 'Cook Medical (U.S.) ', 'Baxter International Inc. (U.S.) ', 'Fresenius Medical Care (Germany) ', 'NIPRO Medical Corporation (Japan) ', 'Vygon SA (France) ', 'Merit Medical Systems, Inc. (U.S.) ', 'Siemens Healthineers (Germany) ', 'Edwards Lifesciences Corporation (U.S.) ', 'PRODIMED (France) ', '3M Company (U.S.) ', 'Access Vascular, Inc. (U.S.) ', 'Medical Components, Inc. (U.S.) ', 'AMECATH (Egypt) '

The increasing incidence of chronic diseases such as cancer, kidney disorders, and cardiovascular conditions drives the global vascular access device market growth. These conditions require long-term therapies, including chemotherapy, dialysis, and intravenous medication. As patient numbers grow, healthcare providers adopt advanced devices to ensure efficient treatment delivery, patient safety, and reduced procedural complications.

Growing Preference for Outpatient and Home Healthcare: Rising outpatient treatments and home healthcare services are driving vascular access device adoption. Portable, user-friendly, and safe devices enable patients to receive intravenous therapies, dialysis, or nutrition at home. This reduces hospital visits, lowers healthcare costs, enhances convenience, and supports broader adoption of vascular access solutions globally.

As per the global vascular access device market analysis, North America dominates the industry, driven by advanced healthcare infrastructure, high prevalence of chronic diseases, and widespread adoption of technologically advanced devices. Continuous R&D, strong presence of leading manufacturers, and favorable reimbursement policies support market growth. Additionally, increasing demand for minimally invasive procedures, AI-assisted insertion systems, and safety-engineered devices further reinforce North America’s position as a key regional leader in vascular access solutions.
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients